1121 TAC-003, a TLR9 agonist antibody conjugate for targeted immunotherapy of Nectin-4 expressing tumors

• Min Li,
• Maria Jose Costa,
• Amy Chen,
• Danielle Fontaine,
• Bora Han,
• Emma RB Sangalang,
• Tiffany Chou,
• Mingrui An,
• Maja Bonacorsi,
• Hong I Wan,
• Pavel Strop

Affiliations

Min Li

School of Public Health, Dalian Medical University, Dalian, Liaoning, China

Maria Jose Costa

1Immune-Onc Therapeutics, Palo Alto, CA, USA

Amy Chen

Tallac Therapeutics Inc., Burlingame, CA, USA

Danielle Fontaine

1Tallac Therapeutics, Burlingame, CA, USA

Bora Han

1Tallac Therapeutics, Burlingame, CA, USA

Emma RB Sangalang

Tallac Therapeutics Inc., Burlingame, CA, USA

Tiffany Chou

Tallac Therapeutics Inc., Burlingame, CA, USA

Mingrui An

Tallac Therapeutics Inc., Burlingame, CA, USA

Maja Bonacorsi

Tallac Therapeutics Inc., Burlingame, CA, USA

Hong I Wan

Tallac Therapeutics Inc., Burlingame, CA, USA

Pavel Strop

Tallac Therapeutics Inc., Burlingame, CA, USA